Immunoglobulin chimeric monomer-dimer hybrids
The invention relates to a chimeric monomer-dimer hybrid protein wherein the protein comprises a first and a second polypeptide chain, the first polypeptide chain comprising at least a portion of an immunoglobulin constant region and a biologically active molecule, and the second polypeptide chain comprising at least a portion of an immunoglobulin constant region without the biologically active molecule of the first chain. The invention also relates to methods of using and methods of making the chimeric monomer-dimer hybrid protein of the invention.
1. A method of making a biologically active chimeric protein comprising:
a) transfecting a cell with (i) a first DNA construct comprising a DNA molecule encoding a first polypeptide comprising a biologically active molecule fused to at least a portion of an immunoglobulin constant region and (ii) a second DNA construct comprising a DNA molecule encoding a second polypeptide comprising at least a portion of an immunoglobulin constant region without a biologically active molecule or variable region of an immunoglobulin;
b) culturing the cell under conditions such that the first polypeptide encoded by said first DNA construct and the second polypeptide encoded by said second DNA construct are expressed; and
c) isolating dimers comprising the first polypeptide and the second polypeptide from said transfected cell.
2. The method of claim 1 , wherein the portion of an immunoglobulin constant region in (i) or the portion of an immunoglobulin constant region in (ii) is an FcRn binding partner.
3. The method of claim 1 , wherein the biologically active molecule is interferon.
4. The method of claim 1 , wherein the biologically active molecule is a viral fusion inhibitor, a growth factor, or a hormone.
5. The method of claim 1 , wherein the biologically active molecule comprises a clotting factor.
6. The method of claim 5 , wherein the clotting factor is Factor VII or Factor VIIa.
7. The method of claim 5 , wherein the clotting, factor is Factor IX.
8. The method of claim 1 , wherein the dimers are isolated by chromatography.
9. The method of claim 1 , wherein the cell is a eukaryotic cell.
10. The method of claim 1 , wherein the eukaryotic cell is a CHO cell.
11. The method of claim 5 , wherein the clotting factor is Factor VIII.
12. A method of making a biologically active chimeric protein comprising:
a) transfecting a first cell with a first DNA construct comprising a DNA molecule encoding a first polypeptide comprising a biologically active molecule fused to at least a portion of an immunoglobulin constant region;
b) transfecting a second cell with a second DNA construct comprising a DNA molecule encoding a second polypeptide comprising at least a portion of an immunoglobulin constant region without a biologically active molecule or variable region of an immunoglobulin;
c) culturing the cells of a) and b) under conditions such that the first polypeptide encoded by the first DNA construct and the second polypeptide encoded by the second DNA construct are expressed together; and
d) isolating dimers of the first polypeptide in a) and the second polypeptide in b) from said transfected cells.
13. The method of claim 12 , wherein the portion of an immunoglobulin constant region in a) or the portion of an immunoglobulin constant region in b) is an FcRn binding partner.
14. The method of claim 12 , wherein the biologically active molecule comprises a clotting factor.
15. The method of claim 14 , wherein the clotting factor is Factor VII or Factor VIIa.
16. The method of claim 14 , wherein the clotting factor is Factor IX.
17. The method of claim 14 , wherein the clotting factor is Factor VIII.
18. The method of claim 12 , wherein the dimers are isolated by chromatography.
19. The method of claim 12 , wherein the first cell or the second cell is a eukaryotic cell.
20. The method of claim 19 , wherein the eukaryotic cell is a CHO cell.
21. The method of claim 1 , wherein the first DNA construct and the second DNA construct are in a vector.
22. The method of claim 12 , wherein the biologically active molecule is interferon.
23. The method of claim 12 , wherein, the biologically active molecule is a viral fusion inhibitor, a growth factor, or a hormone.
24. The method of claim 4 , wherein the growth factor is erythropoietin.
25. The method of claim 23 , wherein the growth factor is erythropoietin.
26. A method of making a biologically active chimeric protein comprising:
a) transfecting a cell with (i) a first DNA construct comprising a DNA molecule encoding a first polypeptide, which comprises a biologically active molecule fused to at least a portion of an immunoglobulin constant region and (ii) a second DNA construct comprising a DNA molecule encoding a second polypeptide, which comprises at least a portion of an immunoglobulin constant region without a biologically active molecule or variable region of an immunoglobulin;
b) culturing the cell under conditions such that the first polypeptide encoded by said first DNA construct and the second polypeptide encoded by said second DNA construct are expressed;
c) isolating dimers comprising the first polypeptide and the second polypeptide, from said transfected cell; and
wherein the biologically, active molecule is Factor VIII.
27. The method of claim 26 , wherein the first DNA construct and the second DNA construct are in a vector.